Wang Li-Shu, Echeveste Carla Elena, Yu Jianhua, Huang Yi-Wen, Lechner John, Mei Ling, Sanvanson Patrick, Yearsley Martha, Wang Chin-Kun, Stoner Gary
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
eFood. 2020 Feb;1(1):53-60. doi: 10.2991/efood.k.200211.001. Epub 2020 Feb 19.
More than 50% of the world's population is infected with Helicobacter pylori. is the major causative agent of gastric ulcers and gastric cancer. eradication using antibiotics either alone or together with a proton pump inhibitor is the primary strategy to decrease the incidence of gastric cancer. Although eradication therapy is effective, there are significant adverse effects and more importantly, resistance to antibiotics occurs, which represents a major therapeutic challenge. Multiple natural products have been shown to suppress both and in animal model systems. However, only a handful of natural products have been evaluated in human clinical trials. The focus of this review is to summarize the results of published human clinical trials to assess the ability of natural products to reduce or eliminate infections. Current evidence suggests that these products appear to have great potential to be developed as pharmaceutical candidates for eradication of , hopefully both antibiotic-sensitive and antibiotic-resistant strains. Frequent consumption of locally produced foodstuff for controlling infection in different countries around the world may well be a feasible long-term solution to fight against this worldwide prevalent pathogen.
全球超过50%的人口感染幽门螺杆菌。幽门螺杆菌是胃溃疡和胃癌的主要致病因素。单独使用抗生素或与质子泵抑制剂联合使用进行根除治疗是降低胃癌发病率的主要策略。尽管根除治疗有效,但存在显著的不良反应,更重要的是,会出现抗生素耐药性,这是一个重大的治疗挑战。在动物模型系统中,多种天然产物已被证明能抑制幽门螺杆菌的生长和活性。然而,只有少数天然产物在人体临床试验中得到评估。本综述的重点是总结已发表的人体临床试验结果,以评估天然产物减少或消除幽门螺杆菌感染的能力。目前的证据表明,这些产品似乎有很大的潜力被开发为根除幽门螺杆菌的候选药物,有望对敏感菌株和耐药菌株均有效。在世界不同国家,经常食用当地生产的食品来控制幽门螺杆菌感染很可能是对抗这种全球流行病原体的一种可行的长期解决方案。